NCT03769935 2023-03-29
Maintenance Therapy for Small-cell Lung Cancer
Qingdao Central Hospital
Phase 2 Completed
Clinical Trials
3 trialsNCT02959749 2018-02-14
Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer
Qingdao Central Hospital
Phase 2/3 Completed
NCT03100955 2017-04-04
A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer
Qingdao University
Phase 3 Unknown